ArticleEuropean journal of nuclear medicine and molecular imaging2022

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study).

Fadi Khreish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.